81 related articles for article (PubMed ID: 25658612)
1. Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Protein Therapeutics Association member companies.
Dichtelmüller HO; Biesert L; Fabbrizzi F; Gajardo R; Gröner A; von Hoegen I; Jorquera JI; Kempf C; Kreil TR; Pifat D; Osheroff W; Poelsler G
Transfusion; 2009 Sep; 49(9):1931-43. PubMed ID: 19497061
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of "Nereid," a new phenol-free detergent to replace Triton X-100 in virus inactivation.
Farcet JB; Kindermann J; Karbiener M; Scheinecker R; Kostner O; Kreil TR
J Med Virol; 2021 Jun; 93(6):3880-3889. PubMed ID: 33274764
[TBL] [Abstract][Full Text] [Related]
3. Viral inactivation for pH-sensitive antibody formats such as multi-specific antibodies.
Duret A; Duarte L; Cahuzac L; Rondepierre A; Lambercier M; Mette R; Recktenwald A; Giovannini R; Bertschinger M
J Biotechnol; 2024 Mar; 384():45-54. PubMed ID: 38403131
[TBL] [Abstract][Full Text] [Related]
4. Preparing for another Ebola Outbreak: The impact of viral inactivation methods on commonly measured biochemistry analytes in plasma and urine.
Zhou J; Sevilleno F; Rokhforooz F; Taher J
Clin Biochem; 2024 Feb; 124():110718. PubMed ID: 38242342
[TBL] [Abstract][Full Text] [Related]
5. Limonium sinense and gallic acid suppress hepatitis C virus infection by blocking early viral entry.
Hsu WC; Chang SP; Lin LC; Li CL; Richardson CD; Lin CC; Lin LT
Antiviral Res; 2015 Jun; 118():139-47. PubMed ID: 25865056
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Elecsys(®) Anti-HCV II assay for routine hepatitis C virus screening of different Asian Pacific populations and detection of early infection.
Yoo SJ; Wang LL; Ning HC; Tao CM; Hirankarn N; Kuakarn S; Yang R; Han TH; Chan RC; Hussain BM; Hussin H; Muliaty D; Shen L; Liu H; Wei L
J Clin Virol; 2015 Mar; 64():20-7. PubMed ID: 25728074
[TBL] [Abstract][Full Text] [Related]
7. Validation of Viral Inactivation Protocols for Therapeutic Blood Products against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-COV-2).
Belem WF; Liu CH; Hu YT; Burnouf T; Lin LT
Viruses; 2022 Oct; 14(11):. PubMed ID: 36366517
[TBL] [Abstract][Full Text] [Related]
8. Contemporary resuscitation of hemorrhagic shock: What will the future hold?
Chipman AM; Jenne C; Wu F; Kozar RA
Am J Surg; 2020 Sep; 220(3):580-588. PubMed ID: 32409009
[TBL] [Abstract][Full Text] [Related]
9. Implementation of Plasma Fractionation in Biological Medicines Production.
Mousavi Hosseini K; Ghasemzadeh M
Iran J Biotechnol; 2016 Dec; 14(4):213-220. PubMed ID: 28959338
[TBL] [Abstract][Full Text] [Related]
10. Towards pathogen inactivation of red blood cells and whole blood targeting viral DNA/RNA: design, technologies, and future prospects for developing countries.
Drew VJ; Barro L; Seghatchian J; Burnouf T
Blood Transfus; 2017 Oct; 15(6):512-521. PubMed ID: 28488960
[TBL] [Abstract][Full Text] [Related]
11. Anti-Human Platelet Antigen-1a Immunoglobulin G Preparation Intended to Prevent Fetal and Neonatal Alloimmune Thrombocytopenia.
Weng YJ; Husebekk A; Skogen B; Kjaer M; Lin LT; Burnouf T
PLoS One; 2016; 11(9):e0162973. PubMed ID: 27627660
[TBL] [Abstract][Full Text] [Related]
12. Solvent/Detergent Virally Inactivated Serum Eye Drops Restore Healthy Ocular Epithelium in a Rabbit Model of Dry-Eye Syndrome.
Tseng CL; Chen ZY; Renn TY; Hsiao SH; Burnouf T
PLoS One; 2016; 11(4):e0153573. PubMed ID: 27100624
[TBL] [Abstract][Full Text] [Related]
13. Impact of Triton X-100 on alpha 2-antiplasmin (SERPINF2) activity in solvent/detergent-treated plasma.
Burnouf T; Goubran HA; Radosevich M; Sayed MA; Gorgy G; El-Ekiaby M
Biologicals; 2007 Oct; 35(4):349-53. PubMed ID: 17656111
[TBL] [Abstract][Full Text] [Related]
14. Dengue virus inactivation by minipool TnBP/Triton X-45 treatment of plasma and cryoprecipitate.
Burnouf T; Chou ML; Cheng LH; Li ZR; Wu YW; El-Ekiaby M; Tsai KH
Vox Sang; 2013 Jan; 104(1):1-6. PubMed ID: 22758375
[TBL] [Abstract][Full Text] [Related]
15. Thermal stability and inactivation of hepatitis C virus grown in cell culture.
Song H; Li J; Shi S; Yan L; Zhuang H; Li K
Virol J; 2010 Feb; 7():40. PubMed ID: 20167059
[TBL] [Abstract][Full Text] [Related]
16. Viral safety of solvent-detergent treated blood products.
Horowitz B; Prince AM; Horowitz MS; Watklevicz C
Dev Biol Stand; 1993; 81():147-61. PubMed ID: 8174797
[TBL] [Abstract][Full Text] [Related]
17. [Virus inactivated plasma].
Köhler M; Wieding JU
Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():73-6. PubMed ID: 8000259
[TBL] [Abstract][Full Text] [Related]
18. TnBP⁄Triton X-45 treatment of plasma for transfusion efficiently inactivates hepatitis C virus.
Chou ML; Burnouf T; Chang SP; Hung TC; Lin CC; Richardson CD; Lin LT
PLoS One; 2015; 10(2):e0117800. PubMed ID: 25658612
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
